The DOI matches its Crossref record; 231 of the 231 references it cites were found in a registry or an index; none of the 179 sources its claims cite is checked for support yet.
Psychiatric disorders and leukocyte telomere length: Underlying mechanisms linking mental illness with cellular aging
Open accessAbstract
Many psychiatric illnesses are associated with early mortality and with an increased risk of developing physical diseases that are more typically seen in the elderly. Moreover, certain psychiatric illnesses may be associated with accelerated cellular aging, evidenced by shortened leukocyte telomere length (LTL), which could underlie this association. Shortened LTL reflects a cell's mitotic history and cumulative exposure to inflammation and oxidation as well as the availability of telomerase, a telomere-lengthening enzyme. Critically short telomeres can cause cells to undergo senescence, apoptosis or genomic instability, and shorter LTL correlates with poorer health and predicts mortality. Emerging data suggest that LTL may be reduced in certain psychiatric illnesses, perhaps in proportion to exposure to the psychiatric illnesses, although conflicting data exist. Telomerase has been less well characterized in psychiatric illnesses, but a role in depression and in antidepressant and neurotrophic effects has been suggested by preclinical and clinical studies. In this article, studies on LTL and telomerase activity in psychiatric illnesses are critically reviewed, potential mediators are discussed, and future directions are suggested. A deeper understanding of cellular aging in psychiatric illnesses could lead to re-conceptualizing them as systemic illnesses with manifestations inside and outside the brain and could identify new treatment targets.
Overview
AI snapshot
Written from the paper’s full text.
TL;DR
This review critically examines evidence linking psychiatric disorders to shortened leukocyte telomere length (LTL) and altered telomerase activity as markers of accelerated cellular aging. It concludes that a modest preponderance of evidence supports LTL shortening in MDD, anxiety disorders, and PTSD, but findings are mixed and causality remains undetermined.
Key findings
- In major depressive disorder (MDD), 11 studies examined LTL; 7 found significantly shorter LTL in currently depressed or mixed mood-disorder groups versus controls, while 4 did not. Effect sizes ranged from 0.04–0.98 (mean Cohen’s d = 0.41; weighted mean Cohen’s d = 0.23).
- Evidence for bipolar disorder, psychotic disorders, anxiety disorders, and PTSD is mixed; the strongest evidence is for MDD. In bipolar disorder, lithium-treated subjects had significantly increased LTL compared with controls, and in the largest schizophrenia study, LTL was unexpectedly longer in schizophrenia subjects than controls.
- “Dose-response” evidence is suggestive but mixed: one MDD study found LTL inversely associated with depression severity and 4-year duration; a longitudinal study found internalizing-disorder duration from ages 11–38 predicted LTL at age 38 in men; other studies did not support this pattern.
- Telomerase activity is less well studied; unmedicated MDD subjects had substantially elevated PBMC basal telomerase activity in a small study, and a meta-analysis of four randomized controlled meditation studies found an effect size of d = 0.46 for increasing PBMC basal telomerase activity.
Methods
- Design: critical/narrative review, not a formal meta-analysis.
- Data: MedLine searches through January 2015 for articles containing “telomeres” or “telomerase” plus psychiatric keywords such as depression, bipolar, anxiety, post-traumatic stress, psychosis, or schizophrenia.
- Analysis: reviewed studies for design, population and control group, diagnostic assessment, sample size and demographics, telomere assay methodology, main findings, effect sizes, and possible confounds; focused primarily on studies using structured DSM diagnoses, with dimensional-symptom studies briefly reviewed in text and not included in summary tables.
Limitations
- Stated: interpreting LTL is complicated by possible leukocyte-subtype redistribution, uncertain relationship to telomere length in other tissues, differences in DNA extraction and assay methods across laboratories, and even slight DNA degradation yielding spurious measurements.
- Stated: many subject-level variables and confounds may affect LTL independently of psychiatric illness, including age, sex, genetics, early-life adversity, socioeconomic status, health behaviors, diet, and latent or active viral infections; psychiatric and medical comorbidities and medication effects also complicate attribution.
- Stated and evident: causality has not been demonstrated, many studies have small sample sizes and methodological differences, and the review is not a formal meta-analysis, so no pooled quantitative estimate or definitive conclusions can be made.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
0 of 179 cited sources checked · 0 supported · 0 flagged
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“In total, 11 studies have investigated LTL in MDD (Table 1).”
§ PSYCHIATRIC DISORDERS AND LEUKOCYTE TELOMERE LENGTH: UNDERLYING MECHANISMS LINKING MENTAL ILLNESS WITH CELLULAR AGING > 2. Telomere Length In Psychiatric Illnesses > 2.2. Major Depressive Disorder
Strength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesNone of the sources cited for this claim have been checked yet.
In the paper
“Of studies having greater than 40 depressed subjects, all except two (Needham et al., 2014; Schaakxs et al., 2015) found significantly shorter LTL in MDD (Hartmann et al., 2010; Hoen et al., 2011; Lung et al., 2007; Simon et al., 2006; Verhoeven et al., 2014a; Wikgren et al., 2012b).”
§ PSYCHIATRIC DISORDERS AND LEUKOCYTE TELOMERE LENGTH: UNDERLYING MECHANISMS LINKING MENTAL ILLNESS WITH CELLULAR AGING > 2. Telomere Length In Psychiatric Illnesses > 2.2. Major Depressive Disorder
What the sources say
- Not checked yetcites Needham et al., 2014
- Not checked yetcites Schaakxs et al., 2015 source
Strength:plain· not yet calibratedCausal:correlational· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesA result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The studies on LTL in MDD are summarized in Table 1, where it is seen that the effect sizes for group differences in LTL ranged from 0.04–0.98 (mean Cohen’s d= 0.41; weighted mean Cohen’s d= 0.23).”
§ PSYCHIATRIC DISORDERS AND LEUKOCYTE TELOMERE LENGTH: UNDERLYING MECHANISMS LINKING MENTAL ILLNESS WITH CELLULAR AGING > 2. Telomere Length In Psychiatric Illnesses > 2.2. Major Depressive Disorder
Strength:plain· not yet calibratedCausal:correlational· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesThe paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“Six studies have examined LTL in BD subjects (type I, type II or rapid cycling) (Table 2).”
§ PSYCHIATRIC DISORDERS AND LEUKOCYTE TELOMERE LENGTH: UNDERLYING MECHANISMS LINKING MENTAL ILLNESS WITH CELLULAR AGING > 2. Telomere Length In Psychiatric Illnesses > 2.3. Bipolar Disorder
Strength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesThe paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“The three remaining studies failed to detect short LTL in schizophrenia.”
§ PSYCHIATRIC DISORDERS AND LEUKOCYTE TELOMERE LENGTH: UNDERLYING MECHANISMS LINKING MENTAL ILLNESS WITH CELLULAR AGING > 2. Telomere Length In Psychiatric Illnesses > 2.4. Psychotic Disorders
Strength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesNone of the sources cited for this claim have been checked yet.
In the paper
“Seven studies have assessed LTL in schizophrenia or other psychotic disorders (Fernandez-Egea et al., 2009; Kao et al., 2008; Kota et al., In press; Malaspina et al., 2014 Mansour et al., 2011; Nieratschker et al., 2013; Yu et al., 2008) (Table 2).”
§ PSYCHIATRIC DISORDERS AND LEUKOCYTE TELOMERE LENGTH: UNDERLYING MECHANISMS LINKING MENTAL ILLNESS WITH CELLULAR AGING > 2. Telomere Length In Psychiatric Illnesses > 2.4. Psychotic Disorders
What the sources say
Strength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIn the paper
“This explanation is similar to the finding with lithium treatment reviewed above (Martinsson et al., 2013), although no clinical studies have yet directly assessed the effect of psychotropic medications on LTL.”
§ PSYCHIATRIC DISORDERS AND LEUKOCYTE TELOMERE LENGTH: UNDERLYING MECHANISMS LINKING MENTAL ILLNESS WITH CELLULAR AGING > 2. Telomere Length In Psychiatric Illnesses > 2.4. Psychotic Disorders
What the sources say
- Not checked yetcites Martinsson et al., 2013 source
Strength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear? Based: unclearThe paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“Critically short telomeres can cause cells to undergo senescence, apoptosis or genomic instability, and shorter LTL correlates with poorer health and predicts mortality.”
§ PSYCHIATRIC DISORDERS AND LEUKOCYTE TELOMERE LENGTH: UNDERLYING MECHANISMS LINKING MENTAL ILLNESS WITH CELLULAR AGING > Abstract
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIn the paper
“For example, the tumor suppressor protein, p53, may be activated, which inhibits oxidative defense mechanisms (such as peroxisome proliferator-activated receptor-gamma coactivator [PGC] 1-α and β, promoting mitochondrial damage and senescence or apoptosis (Sahin et al., 2011) (Fig. 2).”
§ PSYCHIATRIC DISORDERS AND LEUKOCYTE TELOMERE LENGTH: UNDERLYING MECHANISMS LINKING MENTAL ILLNESS WITH CELLULAR AGING > 1. Introduction
What the sources say
- Not checked yetcites Sahin et al., 2011 source
Strength:hedged· not yet calibratedCausal:conditional· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIn the paper
“The particular medical illnesses that are more frequent in these psychiatric conditions are those that are more commonly seen with advanced age, e.g., cardiovascular disease (CVD), stroke, dementia, cancer, obesity, type II diabetes mellitus, osteoporosis (Evans et al., 2005).”
§ PSYCHIATRIC DISORDERS AND LEUKOCYTE TELOMERE LENGTH: UNDERLYING MECHANISMS LINKING MENTAL ILLNESS WITH CELLULAR AGING > 1. Introduction
What the sources say
- Not checked yetcites Evans et al., 2005 source
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passes
- It may state two separate claims as one. 70
- Probably not a substantial claim. 19
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“Emerging data suggest that LTL may be reduced in certain psychiatric illnesses, perhaps in proportion to exposure to the psychiatric illnesses, although conflicting data exist.”
§ PSYCHIATRIC DISORDERS AND LEUKOCYTE TELOMERE LENGTH: UNDERLYING MECHANISMS LINKING MENTAL ILLNESS WITH CELLULAR AGING > Abstract
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“Of these, seven found significantly shorter LTL in currently depressed individuals (or in individuals with mixed mood disorders including MDD) compared to controls (Garcia-Rizo et al., 2013; Hartmann et al., 2010; Hoen et al., 2011; Lung et al., 2007; Simon et al., 2006; Verhoeven et al., 2014a; Wikgren et al., 2012b), while four did not (Needham et al., 2014; Schaakxs et al., 2015; Teyssier et al”
§ PSYCHIATRIC DISORDERS AND LEUKOCYTE TELOMERE LENGTH: UNDERLYING MECHANISMS LINKING MENTAL ILLNESS WITH CELLULAR AGING > 2. Telomere Length In Psychiatric Illnesses > 2.2. Major Depressive Disorder
What the sources say
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“Critically short telomeres can cause cells to undergo senescence, apoptosis or genomic instability, and shorter LTL correlates with poorer health and predicts mortality.”
§ PSYCHIATRIC DISORDERS AND LEUKOCYTE TELOMERE LENGTH: UNDERLYING MECHANISMS LINKING MENTAL ILLNESS WITH CELLULAR AGING > Abstract
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“Many psychiatric illnesses are associated with early mortality and with an increased risk of developing physical diseases that are more typically seen in the elderly.”
§ PSYCHIATRIC DISORDERS AND LEUKOCYTE TELOMERE LENGTH: UNDERLYING MECHANISMS LINKING MENTAL ILLNESS WITH CELLULAR AGING > Abstract
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes? Based: unclearIt may state two separate claims as one.
In the paper
“Telomeres shorten with repeated cell divisions in somatic cells due to incomplete replication of the telomere ends (Fig. 1), replication- and nuclease-associated telomeric DNA damage, and/or chronic exposure to oxidation, certain cytotoxins or inflammation and possibly chronic exposure to the stress hormones, cortisol and catecholamines (Wolkowitz et al., 2011b).”
§ PSYCHIATRIC DISORDERS AND LEUKOCYTE TELOMERE LENGTH: UNDERLYING MECHANISMS LINKING MENTAL ILLNESS WITH CELLULAR AGING > 1. Introduction
What the sources say
- Not checked yetcites Wolkowitz et al., 2011b
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
In the paper
“Rare Mendelian human mutations compromising telomere maintenance or protection genes cause early death and diseases involving a wide variety of tissues and organ systems (Armanios and Blackburn, 2012).”
§ PSYCHIATRIC DISORDERS AND LEUKOCYTE TELOMERE LENGTH: UNDERLYING MECHANISMS LINKING MENTAL ILLNESS WITH CELLULAR AGING > 1. Introduction
What the sources say
- Not checked yetcites Armanios and Blackburn, 2012 source
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Moreover, certain psychiatric illnesses may be associated with accelerated cellular aging, evidenced by shortened leukocyte telomere length (LTL), which could underlie this association.”
§ PSYCHIATRIC DISORDERS AND LEUKOCYTE TELOMERE LENGTH: UNDERLYING MECHANISMS LINKING MENTAL ILLNESS WITH CELLULAR AGING > Abstract
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“Many psychiatric disorders such as major depressive disorder (MDD), bipolar disorder (BD), post-traumatic stress disorder (PTSD) and schizophrenia, are associated with an increased risk of serious medical illnesses (O'Donovan et al., 2011a; Penninx et al., 2013; Viron and Stern, 2010) and premature mortality from natural causes (Viron and Stern, 2010).”
§ PSYCHIATRIC DISORDERS AND LEUKOCYTE TELOMERE LENGTH: UNDERLYING MECHANISMS LINKING MENTAL ILLNESS WITH CELLULAR AGING > 1. Introduction
What the sources say
- Not checked yetcites O'Donovan et al., 2011a
- Not checked yetcites Penninx et al., 2013 source
- Not checked yetcites Viron and Stern, 2010
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“When telomeres reach a critically short length, cells undergo replicative senescence or can become genomically unstable.”
§ PSYCHIATRIC DISORDERS AND LEUKOCYTE TELOMERE LENGTH: UNDERLYING MECHANISMS LINKING MENTAL ILLNESS WITH CELLULAR AGING > 1. Introduction
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesProbably not a substantial claim. It may state two separate claims as one.
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“Shortened LTL reflects a cell’s mitotic history and cumulative exposure to inflammation and oxidation as well as the availability of telomerase, a telomere-lengthening enzyme.”
§ PSYCHIATRIC DISORDERS AND LEUKOCYTE TELOMERE LENGTH: UNDERLYING MECHANISMS LINKING MENTAL ILLNESS WITH CELLULAR AGING > Abstract
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✗ Based: failsProbably not a substantial claim. The paper may give no reason why it holds. It may state two separate claims as one.
In the paper
“Telomeres are dynamic structures, and LTL is in part genetically programmed, with heritability estimates ranging from 0.36–0.84 (Aviv, 2012).”
§ PSYCHIATRIC DISORDERS AND LEUKOCYTE TELOMERE LENGTH: UNDERLYING MECHANISMS LINKING MENTAL ILLNESS WITH CELLULAR AGING > 1. Introduction
What the sources say
- Not checked yetcites Aviv, 2012 source
Strength:plain· not yet calibratedCausal:correlational· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it.
In the paper
“In addition, failure of checkpoints in pre-cancerous cells with critically short telomeres can lead to genomic instability through DNA end-to-end fusions and can promote cancer progression (Maser and DePinho, 2002).”
§ PSYCHIATRIC DISORDERS AND LEUKOCYTE TELOMERE LENGTH: UNDERLYING MECHANISMS LINKING MENTAL ILLNESS WITH CELLULAR AGING > 1. Introduction
What the sources say
- Not checked yetcites Maser and DePinho, 2002 source
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it. It may state two separate claims as one.
In the paper
“Although lifestyle and socioeconomic factors play a role, the psychiatric condition itself may be an independent risk factor (Viron and Stern, 2010).”
§ PSYCHIATRIC DISORDERS AND LEUKOCYTE TELOMERE LENGTH: UNDERLYING MECHANISMS LINKING MENTAL ILLNESS WITH CELLULAR AGING > 1. Introduction
What the sources say
- Not checked yetcites Viron and Stern, 2010
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“Telomerase has been less well characterized in psychiatric illnesses, but a role in depression and in antidepressant and neurotrophic effects has been suggested by preclinical and clinical studies.”
§ PSYCHIATRIC DISORDERS AND LEUKOCYTE TELOMERE LENGTH: UNDERLYING MECHANISMS LINKING MENTAL ILLNESS WITH CELLULAR AGING > Abstract
Strength:hedged· not yet calibratedCausal:conditional· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
In the paper
“In a recent meta-analysis, TL heritability was estimated to be 0.7 (Broer et al., 2013).”
§ PSYCHIATRIC DISORDERS AND LEUKOCYTE TELOMERE LENGTH: UNDERLYING MECHANISMS LINKING MENTAL ILLNESS WITH CELLULAR AGING > 1. Introduction
What the sources say
- Not checked yetcites Broer et al., 2013 source
Strength:hedged· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it.
In the paper
“The reasons for this are unknown, but relatively long telomeres tend to shorten over time, and relatively short telomeres tend to lengthen over time, possibly due to the preferential recruitment of reparative mechanisms such as telomerase activity (TA) (Epel, 2012).”
§ PSYCHIATRIC DISORDERS AND LEUKOCYTE TELOMERE LENGTH: UNDERLYING MECHANISMS LINKING MENTAL ILLNESS WITH CELLULAR AGING > 1. Introduction
What the sources say
- Not checked yetcites Epel, 2012 source
Strength:hedged· not yet calibratedCausal:conditional· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it. It may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“In several studies, not only did baseline LTL correlate with medical illnesses cross-sectionally but predicted the subsequent development of cancers, CVD, diabetes or mortality (Cawthon et al., 2003; Willeit et al 2010; Zhao et al., 2014).”
§ PSYCHIATRIC DISORDERS AND LEUKOCYTE TELOMERE LENGTH: UNDERLYING MECHANISMS LINKING MENTAL ILLNESS WITH CELLULAR AGING > 1. Introduction
What the sources say
Strength:plain· not yet calibratedCausal:correlational· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“Some individuals maintain and may even lengthen average LTL for some periods (Epel, 2012; Muezzinler et al., 2013).”
§ PSYCHIATRIC DISORDERS AND LEUKOCYTE TELOMERE LENGTH: UNDERLYING MECHANISMS LINKING MENTAL ILLNESS WITH CELLULAR AGING > 1. Introduction
What the sources say
Strength:hedged· not yet calibratedCausal:conditional· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it.
In the paper
“In addition, immune cells that have become senescent due to critical telomere shortening (e.g., CD8+CD28− T lymphocytes) hyper-secrete pro-inflammatory cytokines such as interleukin (IL)-6 and tumor necrosis factor (TNF)-α (Effros, 2009), which can lead to a vicious cycle of further inflammation, oxidative stress and telomere shortening.”
§ PSYCHIATRIC DISORDERS AND LEUKOCYTE TELOMERE LENGTH: UNDERLYING MECHANISMS LINKING MENTAL ILLNESS WITH CELLULAR AGING > 1. Introduction
What the sources say
- Not checked yetcites Effros, 2009 source
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“Also, prospective shortening of LTL over relatively short periods of time (2.5 years) has predicted long-term (12 year) cardiovascular mortality in men in one study (Epel et al., 2009a), although not all studies have found this (Weischer et al., 2014).”
§ PSYCHIATRIC DISORDERS AND LEUKOCYTE TELOMERE LENGTH: UNDERLYING MECHANISMS LINKING MENTAL ILLNESS WITH CELLULAR AGING > 1. Introduction
What the sources say
- Not checked yetcites Epel et al., 2009a
- Not checked yetcites Weischer et al., 2014 source
Strength:plain· not yet calibratedCausal:correlational· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it. It may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“(b) the relationship of LTL to TL in other tissues has not been well established, and TL varies by tissue (although TL is generally positively correlated across certain, but not all, tissues within individuals) (Daniali et al., 2013; Dlouha et al., 2014; Friedrich et al., 2000; Gadalla et al., 2010; Lukens et al., 2009; Mitchell et al., 2014; Nakamura et al., 2002; Takubo et al., 2002; Takubo et a”
§ PSYCHIATRIC DISORDERS AND LEUKOCYTE TELOMERE LENGTH: UNDERLYING MECHANISMS LINKING MENTAL ILLNESS WITH CELLULAR AGING > 1. Introduction > 1.1. Caveats in interpreting LTL in psychiatric illnesses
What the sources say
Load-bearingStrength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“There are some studies linking shorter LTL with premature mortality (Cawthon et al., 2003; Fitzpatrick et al., 2011; Weischer et al., 2012) and a reduction in years of healthy living (Njajou et al., 2009).”
§ PSYCHIATRIC DISORDERS AND LEUKOCYTE TELOMERE LENGTH: UNDERLYING MECHANISMS LINKING MENTAL ILLNESS WITH CELLULAR AGING > 1. Introduction
What the sources say
Strength:hedged· not yet calibratedCausal:correlational· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
In the paper
“Leukocyte telomere length generally decreases progressively over the lifespan, with estimates of average attrition rate ranging between 14 to 103 base pairs (bp) per year (weighted mean of 21.9 bp per year) in cross-sectional studies, and between 32.2 to 45.5 bp per year (weighted mean of 40.7 bp per year) in longitudinal studies (Muezzinler et al., 2013).”
§ PSYCHIATRIC DISORDERS AND LEUKOCYTE TELOMERE LENGTH: UNDERLYING MECHANISMS LINKING MENTAL ILLNESS WITH CELLULAR AGING > 1. Introduction
What the sources say
- Not checked yetcites Muezzinler et al., 2013 source
Strength:hedged· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it. It may state two separate claims as one.
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“In summary, LTL is an index and predictor of physical health and of processes associated with biological aging.”
§ PSYCHIATRIC DISORDERS AND LEUKOCYTE TELOMERE LENGTH: UNDERLYING MECHANISMS LINKING MENTAL ILLNESS WITH CELLULAR AGING > 1. Introduction > 1.2 Summary
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✗ Based: failsProbably not a substantial claim. The paper may give no reason why it holds. It may state two separate claims as one.
In the paper
“In the currently depressed subjects, LTL was inversely associated with severity of depression and with the duration of depression over the preceding four years (although longer-term depressive history was not available), suggesting a “dose-response” relationship (see below in sections 2 and 3).”
§ PSYCHIATRIC DISORDERS AND LEUKOCYTE TELOMERE LENGTH: UNDERLYING MECHANISMS LINKING MENTAL ILLNESS WITH CELLULAR AGING > 2. Telomere Length In Psychiatric Illnesses > 2.2. Major Depressive Disorder
What the sources say
- Not checked yetcites Verhoeven et al., 2014a
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
In the paper
“The negative study by Needham et al. (2014) found that individuals with MDD who were receiving antidepressants did have significantly shorter LTL than controls, but depressed individuals not taking antidepressants did not, and the authors speculated that the former group may have had more serious depressions that required medication treatment.”
§ PSYCHIATRIC DISORDERS AND LEUKOCYTE TELOMERE LENGTH: UNDERLYING MECHANISMS LINKING MENTAL ILLNESS WITH CELLULAR AGING > 2. Telomere Length In Psychiatric Illnesses > 2.2. Major Depressive Disorder
What the sources say
- Not checked yetcites Needham et al. (2014)
Strength:plain· not yet calibratedCausal:correlational· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
In the paper
“Elvsåshagen et al found that the total lifetime number of depressive episodes (corrected for age), but not hypomanic episodes, was significantly correlated with the percentage of telomeres shorter than 3,000 bp (by two tailed criteria), consistent with a “dose-response” relationship with depression (Elvsashagen et al., 2011).”
§ PSYCHIATRIC DISORDERS AND LEUKOCYTE TELOMERE LENGTH: UNDERLYING MECHANISMS LINKING MENTAL ILLNESS WITH CELLULAR AGING > 2. Telomere Length In Psychiatric Illnesses > 2.3. Bipolar Disorder
What the sources say
- Not checked yetcites Elvsashagen et al., 2011 source
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
In the paper
“In that study, IgG antibodies to cytomegalovirus (CMV) were significantly elevated in the BD group, and these levels were inversely correlated with LTL, suggesting that exposure to this virus might have played a role in immunosenescence and telomere shortening in the BD group.”
§ PSYCHIATRIC DISORDERS AND LEUKOCYTE TELOMERE LENGTH: UNDERLYING MECHANISMS LINKING MENTAL ILLNESS WITH CELLULAR AGING > 2. Telomere Length In Psychiatric Illnesses > 2.3. Bipolar Disorder
What the sources say
- Not checked yetcites Rizzo et al., 2013 source
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Cumulatively, the bulk of evidence suggests that LTL is decreased in individuals with full syndromal diagnoses of MDD, especially in those with more chronic or severe depression, although the effect size is small..”
§ PSYCHIATRIC DISORDERS AND LEUKOCYTE TELOMERE LENGTH: UNDERLYING MECHANISMS LINKING MENTAL ILLNESS WITH CELLULAR AGING > 2. Telomere Length In Psychiatric Illnesses > 2.2. Major Depressive Disorder
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
In the paper
“The remaining small-scale study that did not find overall differences in LTL between 18 individuals with MDD and 17 controls, did find, in an exploratory analysis, significantly shorter LTL in the more chronically depressed individuals (above the median cumulative duration of active MDD of 9.2 years) (Wolkowitz et al., 2011a).”
§ PSYCHIATRIC DISORDERS AND LEUKOCYTE TELOMERE LENGTH: UNDERLYING MECHANISMS LINKING MENTAL ILLNESS WITH CELLULAR AGING > 2. Telomere Length In Psychiatric Illnesses > 2.2. Major Depressive Disorder
What the sources say
- Not checked yetcites Wolkowitz et al., 2011a
Strength:plain· not yet calibratedn = 18Tests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
In the paper
“Across the MDD group, lifetime untreated depression duration was significantly inversely correlated with LTL, consistent with a “dose-response” relationship, although the pilot sample size was too small too draw meaningful conclusions.”
§ PSYCHIATRIC DISORDERS AND LEUKOCYTE TELOMERE LENGTH: UNDERLYING MECHANISMS LINKING MENTAL ILLNESS WITH CELLULAR AGING > 2. Telomere Length In Psychiatric Illnesses > 2.2. Major Depressive Disorder
What the sources say
- Not checked yetcites Wolkowitz et al., 2011a
Tests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
In the paper
“Despite finding no difference in mean LTL, however, the latter study did find increased expression of p16INK4a and stathmin (STMN1) genes in the depressed sample, which are markers of cellular senescence, telomere dysfunction, microtubule dynamics and biological aging, and are regulators of cell cycle dynamics (Teyssier et al., 2012).”
§ PSYCHIATRIC DISORDERS AND LEUKOCYTE TELOMERE LENGTH: UNDERLYING MECHANISMS LINKING MENTAL ILLNESS WITH CELLULAR AGING > 2. Telomere Length In Psychiatric Illnesses > 2.2. Major Depressive Disorder
What the sources say
- Not checked yetcites Teyssier et al., 2012 source
Load-bearingStrength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
In the paper
“Elvsåshagen and colleagues (Elvsashagen et al., 2011) found the percentage of telomeres shorter than 3,000 bp (“short telomeres”) was increased in BD type II subjects (p= 0.04) and a trend for shortened absolute LTL in the BD type II subjects (p=0.08), although those statistical tests were one-tailed and would not be considered statistically significant by two-tailed criteria.”
§ PSYCHIATRIC DISORDERS AND LEUKOCYTE TELOMERE LENGTH: UNDERLYING MECHANISMS LINKING MENTAL ILLNESS WITH CELLULAR AGING > 2. Telomere Length In Psychiatric Illnesses > 2.3. Bipolar Disorder
What the sources say
- Not checked yetcites Elvsashagen et al., 2011 source
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
In the paper
“The authors suggested that lithium may exert a protective effect against telomere shortening, especially when therapeutically efficacious, and that lithium-induced telomerase activation might be involved, although TA was not measured (Martinsson et al., 2013).”
§ PSYCHIATRIC DISORDERS AND LEUKOCYTE TELOMERE LENGTH: UNDERLYING MECHANISMS LINKING MENTAL ILLNESS WITH CELLULAR AGING > 2. Telomere Length In Psychiatric Illnesses > 2.3. Bipolar Disorder
What the sources say
- Not checked yetcites Martinsson et al., 2013 source
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesProbably not a substantial claim. It may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Overall, the studies of LTL in BD are inconclusive, perhaps due to the effects of medication on LTL.”
§ PSYCHIATRIC DISORDERS AND LEUKOCYTE TELOMERE LENGTH: UNDERLYING MECHANISMS LINKING MENTAL ILLNESS WITH CELLULAR AGING > 2. Telomere Length In Psychiatric Illnesses > 2.3. Bipolar Disorder
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
In the paper
“Since all of the individuals with schizophrenia were receiving psychotropic medication, the authors suggested a similarity of their findings with those of Savolainen et al. (2012) in a mixed inpatient psychiatric sample, which found that telomere lengthening in certain psychiatric patients may be moderated by psychotropic medication usage.”
§ PSYCHIATRIC DISORDERS AND LEUKOCYTE TELOMERE LENGTH: UNDERLYING MECHANISMS LINKING MENTAL ILLNESS WITH CELLULAR AGING > 2. Telomere Length In Psychiatric Illnesses > 2.4. Psychotic Disorders
What the sources say
- Not checked yetcites Savolainen et al. (2012) source
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesProbably not a substantial claim. It may state two separate claims as one.
In the paper
“Yu et al. (2008) found shorter LTL in individuals with schizophrenia who responded poorly to treatment but not in the schizophrenia group as a whole.”
§ PSYCHIATRIC DISORDERS AND LEUKOCYTE TELOMERE LENGTH: UNDERLYING MECHANISMS LINKING MENTAL ILLNESS WITH CELLULAR AGING > 2. Telomere Length In Psychiatric Illnesses > 2.4. Psychotic Disorders
What the sources say
- Not checked yetcites Yu et al. (2008)
Strength:plain· not yet calibratedCausal:correlational· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
In the paper
“Mansour et al. (2011), studying a relatively young, highly inbred population, found no significant LTL difference in schizophrenia vs. controls, but LTL was confounded by the extent of inbreeding in the schizophrenia population, and no data were available regarding comorbid diagnoses, medications or treatment response.”
§ PSYCHIATRIC DISORDERS AND LEUKOCYTE TELOMERE LENGTH: UNDERLYING MECHANISMS LINKING MENTAL ILLNESS WITH CELLULAR AGING > 2. Telomere Length In Psychiatric Illnesses > 2.4. Psychotic Disorders
What the sources say
- Not checked yetcites Mansour et al. (2011) source
Strength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
In the paper
“The cumulative amount of time receiving lithium over the preceding 30 months was associated with increased LTL, and lithium responders had longer LTL than lithium non-responders.”
§ PSYCHIATRIC DISORDERS AND LEUKOCYTE TELOMERE LENGTH: UNDERLYING MECHANISMS LINKING MENTAL ILLNESS WITH CELLULAR AGING > 2. Telomere Length In Psychiatric Illnesses > 2.3. Bipolar Disorder
What the sources say
- Not checked yetcites Martinsson et al., 2013 source
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
In the paper
“Most recently, Lima et al. (2014) corroborated shorter LTL in BD, although they lacked data on duration of illness and medication treatment.”
§ PSYCHIATRIC DISORDERS AND LEUKOCYTE TELOMERE LENGTH: UNDERLYING MECHANISMS LINKING MENTAL ILLNESS WITH CELLULAR AGING > 2. Telomere Length In Psychiatric Illnesses > 2.3. Bipolar Disorder
What the sources say
- Not checked yetcites Lima et al. (2014)
Strength:plain· not yet calibratedCausal:correlational· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
In the paper
“The largest study to date (comprising 539 schizophrenia subjects and 519 controls) (Nieratschker et al., 2013) reported an unexpected increase in LTL in individuals with schizophrenia in comparison to healthy controls, especially in the younger subjects.”
§ PSYCHIATRIC DISORDERS AND LEUKOCYTE TELOMERE LENGTH: UNDERLYING MECHANISMS LINKING MENTAL ILLNESS WITH CELLULAR AGING > 2. Telomere Length In Psychiatric Illnesses > 2.4. Psychotic Disorders
What the sources say
- Not checked yetcites Nieratschker et al., 2013 source
Tests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
In the paper
“In one study, LTL was significantly shortened in individuals with schizophrenia and was unrelated to antipsychotic use or duration of illness (Kao et al., 2008).”
§ PSYCHIATRIC DISORDERS AND LEUKOCYTE TELOMERE LENGTH: UNDERLYING MECHANISMS LINKING MENTAL ILLNESS WITH CELLULAR AGING > 2. Telomere Length In Psychiatric Illnesses > 2.4. Psychotic Disorders
What the sources say
- Not checked yetcites Kao et al., 2008 source
Strength:plain· not yet calibratedCausal:correlational· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
In the paper
“Most recently, Malaspina et al. (2014) reported no significant difference in LTL between medicated individuals with schizophrenia compared to controls, but the control sample size was small, and the psychiatric history of the controls was assessed only for the preceding two years.”
§ PSYCHIATRIC DISORDERS AND LEUKOCYTE TELOMERE LENGTH: UNDERLYING MECHANISMS LINKING MENTAL ILLNESS WITH CELLULAR AGING > 2. Telomere Length In Psychiatric Illnesses > 2.4. Psychotic Disorders
What the sources say
- Not checked yetcites Malaspina et al. (2014) source
Strength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Therefore, it is unlikely that LTL measurement, used alone, will come into clinical practice as a diagnostic biomarker, let alone a diagnostic aid in psychiatric diagnoses.”
§ PSYCHIATRIC DISORDERS AND LEUKOCYTE TELOMERE LENGTH: UNDERLYING MECHANISMS LINKING MENTAL ILLNESS WITH CELLULAR AGING > 2. Telomere Length In Psychiatric Illnesses > 2.6. Post-Traumatic Stress Disorder (PTSD)
Load-bearingStrength:hedged· not yet calibratedTests✓ Asserted: passes? Checkable: unclear✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“Oxidative stress markers are inversely correlated with LTL in MDD (Wolkowitz et al., 2011a) and in healthy pre-menopausal women (Epel et al., 2004).”
§ PSYCHIATRIC DISORDERS AND LEUKOCYTE TELOMERE LENGTH: UNDERLYING MECHANISMS LINKING MENTAL ILLNESS WITH CELLULAR AGING > 4. Potential Mediators of Telomere Shortening in Psychiatric Illness > 4.2. Inflammation, Oxidation and Increased Cell Turnover
What the sources say
- Not checked yetcites Wolkowitz et al., 2011a
- Not checked yetcites Epel et al., 2004 source
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
In the paper
“However, LTL was significantly shorter among the older anxiety disorder subjects (48–87 years of age) compared to controls, and the authors suggested that more prolonged exposure to anxiety disorder-related stress might be needed for accelerated telomere shortening to be detected (Kananen et al., 2010).”
§ PSYCHIATRIC DISORDERS AND LEUKOCYTE TELOMERE LENGTH: UNDERLYING MECHANISMS LINKING MENTAL ILLNESS WITH CELLULAR AGING > 2. Telomere Length In Psychiatric Illnesses > 2.5. Anxiety Disorders
What the sources say
- Not checked yetcites Kananen et al., 2010 source
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesProbably not a substantial claim.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“In summary, the data are mixed, but the evidence tends to support LTL shortening in anxiety disorders, especially with more severe anxiety disorders (meeting full diagnostic criteria) and with longer exposure to the anxiety disorder.”
§ PSYCHIATRIC DISORDERS AND LEUKOCYTE TELOMERE LENGTH: UNDERLYING MECHANISMS LINKING MENTAL ILLNESS WITH CELLULAR AGING > 2. Telomere Length In Psychiatric Illnesses > 2.5. Anxiety Disorders
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“In summary, although the number of studies is small, the existing evidence base is consistent with LTL shortening in PTSD, although several confounds, especially early life adversity, exist, making conclusions difficult.”
§ PSYCHIATRIC DISORDERS AND LEUKOCYTE TELOMERE LENGTH: UNDERLYING MECHANISMS LINKING MENTAL ILLNESS WITH CELLULAR AGING > 2. Telomere Length In Psychiatric Illnesses > 2.6. Post-Traumatic Stress Disorder (PTSD)
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
In the paper
“In a large-scale study, while phobic anxiety was not overall significantly correlated with LTL, there was evidence of a threshold or “dose-response” effect, with more severe phobia being associated with shorter LTL (Okereke et al., 2012).”
§ PSYCHIATRIC DISORDERS AND LEUKOCYTE TELOMERE LENGTH: UNDERLYING MECHANISMS LINKING MENTAL ILLNESS WITH CELLULAR AGING > 2. Telomere Length In Psychiatric Illnesses > 2.5. Anxiety Disorders
What the sources say
- Not checked yetcites Okereke et al., 2012 source
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
In the paper
“This differed from this group’s finding, using the same study population, that remitted MDD was still associated with shortened LTL (Verhoeven et al., 2014a), and they suggested that LTL shortening with anxiety disorders may be more reversible than that associated with MDD.”
§ PSYCHIATRIC DISORDERS AND LEUKOCYTE TELOMERE LENGTH: UNDERLYING MECHANISMS LINKING MENTAL ILLNESS WITH CELLULAR AGING > 2. Telomere Length In Psychiatric Illnesses > 2.5. Anxiety Disorders
What the sources say
- Not checked yetcites Verhoeven et al., 2014a
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesProbably not a substantial claim.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“In summary, data on LTL in schizophrenia and other psychotic disorders are mixed, and it is possible that age, medication exposure, treatment response, comrbidities and confounds may explain some of the variability in findings.”
§ PSYCHIATRIC DISORDERS AND LEUKOCYTE TELOMERE LENGTH: UNDERLYING MECHANISMS LINKING MENTAL ILLNESS WITH CELLULAR AGING > 2. Telomere Length In Psychiatric Illnesses > 2.4. Psychotic Disorders
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“Pro-inflammatory cytokine concentrations are inversely correlated with LTL in MDD (Wolkowitz et al., 2011a), in individuals with histories of early life stress (Kiecolt-Glaser et al., 2011), and in healthy individuals with high C-reactive protein levels or high cumulative inflammatory load (O'Donovan et al., 2011b; Revesz et al., 2013).”
§ PSYCHIATRIC DISORDERS AND LEUKOCYTE TELOMERE LENGTH: UNDERLYING MECHANISMS LINKING MENTAL ILLNESS WITH CELLULAR AGING > 4. Potential Mediators of Telomere Shortening in Psychiatric Illness > 4.2. Inflammation, Oxidation and Increased Cell Turnover
What the sources say
- Not checked yetcites Wolkowitz et al., 2011a
- Not checked yetcites Kiecolt-Glaser et al., 2011 source
- Not checked yetcites O'Donovan et al., 2011b
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“Since such biochemical abnormalities cut across traditional psychiatric diagnoses (Pandya et al., 2013; Rosenblat et al., 2014; Smyth and Lawrie, 2013), telomere shortening may be related to specific biological processes or endophenotypes more than to specific diagnostic categories, although this remains to be adequately tested.”
§ PSYCHIATRIC DISORDERS AND LEUKOCYTE TELOMERE LENGTH: UNDERLYING MECHANISMS LINKING MENTAL ILLNESS WITH CELLULAR AGING > 4. Potential Mediators of Telomere Shortening in Psychiatric Illness > 4.1. Overview
What the sources say
- Not checked yetcites Pandya et al., 2013 source
- Not checked yetcites Rosenblat et al., 2014
- Not checked yetcites Smyth and Lawrie, 2013
Strength:hedged· not yet calibratedCausal:correlational· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“As seen from the above reviews, there are inconsistent reports of LTL associations with psychiatric illnesses with the strongest evidence seen in MDD.”
§ PSYCHIATRIC DISORDERS AND LEUKOCYTE TELOMERE LENGTH: UNDERLYING MECHANISMS LINKING MENTAL ILLNESS WITH CELLULAR AGING > 2. Telomere Length In Psychiatric Illnesses > 2.6. Post-Traumatic Stress Disorder (PTSD)
Strength:plain· not yet calibratedCausal:correlational· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“Biological abnormalities seen in certain psychiatric conditions (e.g. inflammation, oxidative stress and perhaps changes in steroids or in biogenic amine activity) are associated with, and may cause, telomere shortening (Wolkowitz et al., 2011a; Wolkowitz et al., 2011b).”
§ PSYCHIATRIC DISORDERS AND LEUKOCYTE TELOMERE LENGTH: UNDERLYING MECHANISMS LINKING MENTAL ILLNESS WITH CELLULAR AGING > 4. Potential Mediators of Telomere Shortening in Psychiatric Illness > 4.1. Overview
What the sources say
- Not checked yetcites Wolkowitz et al., 2011a
- Not checked yetcites Wolkowitz et al., 2011b
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“There is a modest preponderance of evidence suggesting that shorter LTL is seen across these illnesses, although methodological differences and, in many cases, small sample sizes preclude more definitive conclusions.”
§ PSYCHIATRIC DISORDERS AND LEUKOCYTE TELOMERE LENGTH: UNDERLYING MECHANISMS LINKING MENTAL ILLNESS WITH CELLULAR AGING > 2. Telomere Length In Psychiatric Illnesses > 2.6. Post-Traumatic Stress Disorder (PTSD)
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“Two post-mortem studies of TL in cerebellar gray matter and occipital cortex found no significant differences between MDD subjects and controls, although correlations with LTL were not assessed (Teyssier et al., 2010; Zhang et al., 2010).”
§ PSYCHIATRIC DISORDERS AND LEUKOCYTE TELOMERE LENGTH: UNDERLYING MECHANISMS LINKING MENTAL ILLNESS WITH CELLULAR AGING > 6. Relationship of Peripheral Cell Aging Markers to the Brain
What the sources say
Strength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“In summary, there have not yet been enough studies, especially large-scale ones, in psychiatric populations to assess possible changes in PBMC basal TA, although stress seems a potent regulator of TA, even though the direction and mechanisms of these effects are unknown at this time.”
§ PSYCHIATRIC DISORDERS AND LEUKOCYTE TELOMERE LENGTH: UNDERLYING MECHANISMS LINKING MENTAL ILLNESS WITH CELLULAR AGING > 5. Telomerase Activity (TA) in Psychiatric Illness > 5.2. Telomerase Activity (TA) in Psychiatric Illnesses
Strength:hedged· not yet calibratedCausal:conditional· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
What the paper did — it cites no source for this, so there is none to check. The quote shows it is in the paper.
In the paper
“Further, these studies have often been non-randomized and not adequately controlled.”
§ PSYCHIATRIC DISORDERS AND LEUKOCYTE TELOMERE LENGTH: UNDERLYING MECHANISMS LINKING MENTAL ILLNESS WITH CELLULAR AGING > 7. Is Cellular Aging Preventable or Reversible?
Strength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
In the paper
“A recent population-based study, not specifically in MDD, found that LTL was positively associated with total cerebral volume, including white and cortical matter gray volume, as well as with hippocampal volume and volumes of several other sub-regions (King et al., 2014).”
§ PSYCHIATRIC DISORDERS AND LEUKOCYTE TELOMERE LENGTH: UNDERLYING MECHANISMS LINKING MENTAL ILLNESS WITH CELLULAR AGING > 6. Relationship of Peripheral Cell Aging Markers to the Brain
What the sources say
- Not checked yetcites King et al., 2014 source
Strength:plain· not yet calibratedCausal:correlational· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Without determining their relationship to neural process that are presumably more closely related to psychiatric illnesses, their ultimate informational value will be limited.”
§ PSYCHIATRIC DISORDERS AND LEUKOCYTE TELOMERE LENGTH: UNDERLYING MECHANISMS LINKING MENTAL ILLNESS WITH CELLULAR AGING > 6. Relationship of Peripheral Cell Aging Markers to the Brain
Tests✓ Asserted: passes✗ Checkable: fails✓ Load-bearing: passes✓ Based: passesProbably not a substantial claim. It may be too vague to check against evidence.
- Rests on an assumption: Peripheral markers of cell aging are the only markers that are practical to obtain in living humans.
In the paper
“These preclinical studies suggest that hippocampal TA in mice is involved in the regulation of “depression-like” behaviors and possibly “antidepressant-like” mechanisms, perhaps by regulating adult neurogenesis in the dentate gyrus (Zhou et al., 2011).”
§ PSYCHIATRIC DISORDERS AND LEUKOCYTE TELOMERE LENGTH: UNDERLYING MECHANISMS LINKING MENTAL ILLNESS WITH CELLULAR AGING > 5. Telomerase Activity (TA) in Psychiatric Illness > 5.1. Overview
What the sources say
- Not checked yetcites Zhou et al., 2011 source
Strength:hedged· not yet calibratedCausal:conditional· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
In the paper
“In this study, baseline PBMC basal TA was controlled for, but potential limitations were that the active group was heterogeneous in terms of treatment received and time since treatment completion.”
§ PSYCHIATRIC DISORDERS AND LEUKOCYTE TELOMERE LENGTH: UNDERLYING MECHANISMS LINKING MENTAL ILLNESS WITH CELLULAR AGING > 7. Is Cellular Aging Preventable or Reversible?
What the sources say
- Not checked yetcites Lengacher et al., 2014 source
Strength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The behavioral/ psychological/ lifestyle intervention literature relating these interventions to PBMC basal TA and LTL is intriguing and points in the hypothesized direction, but it is limited by the small-scale, non-randomized, non-blinded design of the studies, as well as, in most cases, the short duration of the interventions.”
§ PSYCHIATRIC DISORDERS AND LEUKOCYTE TELOMERE LENGTH: UNDERLYING MECHANISMS LINKING MENTAL ILLNESS WITH CELLULAR AGING > 7. Is Cellular Aging Preventable or Reversible?
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
- Rests on an assumption: It is difficult to double-blind behavioral and psychological interventions.
In the paper
“A five-year follow-up of ten of the original participants from that study showed that their LTL significantly increased from baseline relative to control men whose prostate cancer was simply followed by active surveillance, although their PBMC basal TA had decreased somewhat compared to the baseline measurement (Ornish et al., 2013).”
§ PSYCHIATRIC DISORDERS AND LEUKOCYTE TELOMERE LENGTH: UNDERLYING MECHANISMS LINKING MENTAL ILLNESS WITH CELLULAR AGING > 7. Is Cellular Aging Preventable or Reversible?
What the sources say
- Not checked yetcites Ornish et al., 2013 source
Tests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
In the paper
“A potential limitation of this study was the lack of a control group and the fact that only 30 of 126 eligible patients agreed to participate in the study after learning the details and the fact that all participants were male, which may affect generalizability of the findings.”
§ PSYCHIATRIC DISORDERS AND LEUKOCYTE TELOMERE LENGTH: UNDERLYING MECHANISMS LINKING MENTAL ILLNESS WITH CELLULAR AGING > 7. Is Cellular Aging Preventable or Reversible?
What the sources say
- Not checked yetcites Ornish et al., 2008 source
Strength:hedged· not yet calibratedn = 126Tests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
In the paper
“Analyses in this study were cross-sectional, thus causality cannot be inferred, and data on diet, another lifestyle factor that can influence LTL, were not available.”
§ PSYCHIATRIC DISORDERS AND LEUKOCYTE TELOMERE LENGTH: UNDERLYING MECHANISMS LINKING MENTAL ILLNESS WITH CELLULAR AGING > 7. Is Cellular Aging Preventable or Reversible?
What the sources say
- Not checked yetcites Puterman et al., 2013 source
Strength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
In the paper
“One additional small-scale study involving telephone-based psychological stress-reduction counseling in 22 women with cervical cancer (Biegler et al., 2012), found no significant overall change in LTL following four months of counseling, but did find that changes in distress ratings over that time period were inversely correlated with changes in LTL (Biegler et al., 2012).”
§ PSYCHIATRIC DISORDERS AND LEUKOCYTE TELOMERE LENGTH: UNDERLYING MECHANISMS LINKING MENTAL ILLNESS WITH CELLULAR AGING > 7. Is Cellular Aging Preventable or Reversible?
What the sources say
- Not checked yetcites Biegler et al., 2012 source
Tests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
In the paper
“This study was limited by the small sample size (10 subjects in the intervention group and 25 controls) and by the non-randomized study design, which may introduce unknown sources of bias.”
§ PSYCHIATRIC DISORDERS AND LEUKOCYTE TELOMERE LENGTH: UNDERLYING MECHANISMS LINKING MENTAL ILLNESS WITH CELLULAR AGING > 7. Is Cellular Aging Preventable or Reversible?
What the sources say
- Not checked yetcites Ornish et al., 2013 source
Strength:hedged· not yet calibratedn = 10Tests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
In the paper
“The literature on exercise and telomere length is inconsistent but generally suggests that exercise is associated with a telomere-protective phenotype in leukocytes and skeletal muscles (Ludlow et al., 2013).”
§ PSYCHIATRIC DISORDERS AND LEUKOCYTE TELOMERE LENGTH: UNDERLYING MECHANISMS LINKING MENTAL ILLNESS WITH CELLULAR AGING > 7. Is Cellular Aging Preventable or Reversible?
What the sources say
- Not checked yetcites Ludlow et al., 2013 source
Strength:hedged· not yet calibratedCausal:correlational· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
In the paper
“The same group of investigators previously found, in a group of caregiving and non-caregiving post-menopausal women, that highly stressed women have shorter telomeres, but only if they are inactive, suggesting a protective effect of exercise (Puterman et al., 2010).”
§ PSYCHIATRIC DISORDERS AND LEUKOCYTE TELOMERE LENGTH: UNDERLYING MECHANISMS LINKING MENTAL ILLNESS WITH CELLULAR AGING > 7. Is Cellular Aging Preventable or Reversible?
What the sources say
- Not checked yetcites Puterman et al., 2010 source
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
What the paper did — it cites no source for this, so there is none to check. The quote shows it is in the paper.
In the paper
“Further, health behaviors may have been spuriously associated with LTL if physical diseases (that could, themselves, lessen healthful health behaviors) bore the primary relationship with LTL.”
§ PSYCHIATRIC DISORDERS AND LEUKOCYTE TELOMERE LENGTH: UNDERLYING MECHANISMS LINKING MENTAL ILLNESS WITH CELLULAR AGING > 7. Is Cellular Aging Preventable or Reversible?
Strength:hedged· not yet calibratedCausal:correlational· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it.
In the paper
“The putative effects of certain of these interventions on cellular aging may be mediated by improvements in stress arousal and lessening of threat cognitions and ruminative thought (Epel et al., 2009b), although the biochemical intermediaries remain to be determined.”
§ PSYCHIATRIC DISORDERS AND LEUKOCYTE TELOMERE LENGTH: UNDERLYING MECHANISMS LINKING MENTAL ILLNESS WITH CELLULAR AGING > 7. Is Cellular Aging Preventable or Reversible?
What the sources say
- Not checked yetcites Epel et al., 2009b
Strength:hedged· not yet calibratedCausal:conditional· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it. It may state two separate claims as one.
In the paper
“Since that study was cross-sectional, though, it is difficult to draw causal interpretations, especially since the more highly stressed women were less likely to be physically active.”
§ PSYCHIATRIC DISORDERS AND LEUKOCYTE TELOMERE LENGTH: UNDERLYING MECHANISMS LINKING MENTAL ILLNESS WITH CELLULAR AGING > 7. Is Cellular Aging Preventable or Reversible?
What the sources say
- Not checked yetcites Puterman et al., 2010 source
Strength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
In the paper
“This study, however, had no control group, and four months may be too short to discern significant changes in LTL.”
§ PSYCHIATRIC DISORDERS AND LEUKOCYTE TELOMERE LENGTH: UNDERLYING MECHANISMS LINKING MENTAL ILLNESS WITH CELLULAR AGING > 7. Is Cellular Aging Preventable or Reversible?
What the sources say
- Not checked yetcites Biegler et al., 2012 source
Strength:hedged· not yet calibratedn = 22Tests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“In an otherwise concerning picture, findings that certain positive lifestyle changes are correlated with lowered degrees of cell aging (as indexed by LTL and/or PBMC basal TA) (Epel, 2009; Epel, 2012; Hoge et al., 2013; Puterman et al., 2010; Puterman et al., 2015) provide some encouragement, although many of the studies were small-scale, open-label or inadequately controlled.”
§ PSYCHIATRIC DISORDERS AND LEUKOCYTE TELOMERE LENGTH: UNDERLYING MECHANISMS LINKING MENTAL ILLNESS WITH CELLULAR AGING > 8. Summary
What the sources say
Strength:hedged· not yet calibratedCausal:correlational· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
- Rests on an assumption: Shorter LTL has been linked to current and future medical illnesses and to premature mortality.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The relatively small effect sizes reported in reviewed positive studies, as well as the lack of diagnostic specificity of LTL and PBMC basal TA changes, also argue against the use of such markers as diagnostic tools, in isolation from other measures, at this time.”
§ PSYCHIATRIC DISORDERS AND LEUKOCYTE TELOMERE LENGTH: UNDERLYING MECHANISMS LINKING MENTAL ILLNESS WITH CELLULAR AGING > 8. Summary
Load-bearingStrength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesProbably not a substantial claim.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“A modest preponderance of the evidence reviewed here suggests that several psychiatric illnesses (viz., MDD, anxiety disorders and PTSD) may be associated with accelerated cellular aging, as indexed by short LTL and possibly by altered PBMC basal TA, although conflicting reports exist, and no conclusions can yet be made.”
§ PSYCHIATRIC DISORDERS AND LEUKOCYTE TELOMERE LENGTH: UNDERLYING MECHANISMS LINKING MENTAL ILLNESS WITH CELLULAR AGING > 8. Summary
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Methodological differences between studies, as well as many studies with small sample sizes, make conclusions difficult to draw.”
§ PSYCHIATRIC DISORDERS AND LEUKOCYTE TELOMERE LENGTH: UNDERLYING MECHANISMS LINKING MENTAL ILLNESS WITH CELLULAR AGING > 8. Summary
Load-bearingStrength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
The paper relies on this without support.
Peripheral markers of cell aging are the only markers that are practical to obtain in living humans.
“In summary, peripheral markers of cell aging are the only markers that are practical to obtain in living humans.”
The paper relies on this without support.
It is difficult to double-blind behavioral and psychological interventions.
“However, it is obviously difficult to double-blind such interventions.”
The paper relies on this without support.
Shorter LTL has been linked to current and future medical illnesses and to premature mortality.
“Evidence of significant LTL shortening in psychiatric illness would be cause for concern, since shorter LTL has been linked to current and future medical illnesses and to premature mortality, although causality has not been demonstrated.”
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Psychological stress is known to trigger inflammatory response and premature shortening of telomere length, leading to cellular senescence, which is characteristic of aging (Lindqvist et al, 2015).”
From Microglia Priming with Aging and Stress (2017) · cites this paper as Lindqvist et al, 2015
Citations
Cites
Diagnostic and Statistical Manual of Mental Disorders
American Psychiatric Association (2013) · doi:10.1176/appi.books.9780890425596 · Cited by 116,369
Diagnostic and Statistical Manual of Mental Disorders
Williams, J. B. W., & First, M. B. (2013) · Oxford University Press eBooks · doi:10.1093/acrefore/9780199975839.013.104 · Cited by 109,845
Kessler, R. C. (1994) · Archives of General Psychiatry · doi:10.1001/archpsyc.1994.03950010008002 · Cited by 12,370
Diagnostic and Statistical Manual of Mental Disorders, 5th Edition
(2013) · American Psychiatric Association Publishing eBooks · doi:10.1176/appi.books.9780890425596.893619 · Cited by 4,412
Accelerated telomere shortening in response to life stress
Epel, E. S., Blackburn, E. H., Lin, J., Dhabhar, F. S., Adler, N. E., Morrow, J. D., & Cawthon, R. M. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0407162101 · Cited by 3,002
Self-citationOxidative stress shortens telomeres
von Zglinicki, T. (2002) · Trends in Biochemical Sciences · doi:10.1016/s0968-0004(02)02110-2 · Cited by 2,524
Highly Recurrent TERT Promoter Mutations in Human Melanoma
Huang, F. W., Hodis, E., Xu, M. J., Kryukov, G. V., Chin, L., & Garraway, L. A. (2013) · Science · doi:10.1126/science.1229259 · Cited by 1,816
TERT Promoter Mutations in Familial and Sporadic Melanoma
Horn, S., Figl, A., Rachakonda, P. S., Fischer, C., Sucker, A., Gast, A., Kadel, S., Moll, I., Nagore, E., Hemminki, K., et al. (2013) · Science · doi:10.1126/science.1230062 · Cited by 1,799
Association between telomere length in blood and mortality in people aged 60 years or older
Cawthon, R. M., Smith, K. R., O'Brien, E., Sivatchenko, A., & Kerber, R. A. (2003) · The Lancet · doi:10.1016/s0140-6736(03)12384-7 · Cited by 1,761
Telomere dysfunction induces metabolic and mitochondrial compromise
Sahin, E., Colla, S., Liesa, M., Moslehi, J., Müller, F. L., Guo, M., Cooper, M., Kotton, D., Fabian, A. J., Walkey, C., et al. (2011) · Nature · doi:10.1038/nature09787 · Cited by 1,319
Flagged first, then by citations
Cited by
Sorted by citations
Items 101–200 of 285
The implications of war captivity and long-term psychopathology trajectories for telomere length
Solomon, Z., Tsur, N., Levin, Y., Uziel, O., Lahav, M., & Ohry, A. (2017) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2017.04.004 · Cited by 32
Ben‐Azu, B., del Re, E. C., VanderZwaag, J., Carrier, M., Keshavan, M. S., Khakpour, M., & Tremblay, M. (2023) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2023.1139357 · Cited by 32
CHRONICITY OF DEPRESSION AND MOLECULAR MARKERS IN A LARGE SAMPLE OF HAN CHINESE WOMEN
Edwards, A. C., Aggen, S. H., Cai, N., Bigdeli, T. B., Peterson, R. E., Docherty, A. R., Webb, B. T., Bacanu, S., Flint, J., & Kendler, K. S. (2016) · Depression and Anxiety · doi:10.1002/da.22517 · Cited by 31
Schizophrenia and Physical Comorbidity.
Filipčić, I. Š., & Filipčić, I. (2018) · PubMed · Cited by 32
Frailty Index as a clinical measure of biological age in psychiatry
Bersani, F. S., Canevelli, M., Cesari, M., Maggioni, E., Pasquini, M., Wolkowitz, O. M., Ferracuti, S., Biondi, M., & Bruno, G. (2020) · Journal of Affective Disorders · doi:10.1016/j.jad.2020.03.015 · Cited by 33
Self-citationBlood-based mitochondrial respiratory chain function in major depression
Fernström, J., Mellon, S. H., McGill, M. A., Picard, M. A., Reus, V. I., Hough, C. M., Lin, J., Epel, E. S., Wolkowitz, O. M., & Lindqvist, D. (2021) · Translational Psychiatry · doi:10.1038/s41398-021-01723-x · Cited by 39
Self-citationTelomere Biology in Mood Disorders: An Updated, Comprehensive Review of the Literature
Muneer, A., & Minhas, F. A. (2019) · Clinical Psychopharmacology and Neuroscience · doi:10.9758/cpn.2019.17.3.343 · Cited by 32
Accelerated biological aging in serious mental disorders
Wolkowitz, O. M. (2018) · World Psychiatry · doi:10.1002/wps.20546 · Cited by 32
Self-citationMutz, J., & Lewis, C. M. (2022) · Biological Psychiatry Global Open Science · doi:10.1016/j.bpsgos.2022.08.008 · Cited by 30
Telomere length and epigenetic age acceleration in adolescents with anxiety disorders
de Baumont, A. C., Hoffmann, M. S., Bortoluzzi, A., Fries, G. R., Lavandoski, P., Grün, L. K., Guimarães, L. S. P., Guma, F. T. C. R., Salum, G. A., Barbé‐Tuana, F. M., et al. (2021) · Scientific Reports · doi:10.1038/s41598-021-87045-w · Cited by 31
Ciubuc-Batcu, M. T., Stapelberg, N. J. C., Headrick, J. P., & Renshaw, G. M. C. (2023) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2023.166920 · Cited by 31
Bersani, F. S., Wolkowitz, O. M., Milush, J. M., Sinclair, E., Epling, L., Aschbacher, K., Lindqvist, D., Yehuda, R., Flory, J. D., Bierer, L. M., et al. (2016) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2016.03.021 · Cited by 29
Self-citationTelomere length and hTERT in mania and subsequent remission
Çınar, R. K. (2017) · Brazilian Journal of Psychiatry · doi:10.1590/1516-4446-2017-2216 · Cited by 29
Pawełczyk, T., Grancow-Grabka, M., Trafalska, E., Szemraj, J., Żurner, N., & Pawełczyk, A. M. (2017) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2017.12.008 · Cited by 29
In vivo biomarkers of structural and functional brain development and aging in humans
Franke, K., Bublak, P., Hoyer, D., Billiet, T., Gaser, C., Witte, O. W., & Schwab, M. G. (2020) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2017.11.002 · Cited by 29
Kim, T. Y., Kim, S. J., Choi, J. R., Lee, S., Kim, J., Hwang, I. S., Chung, H. G., Choi, J. H., Kim, H. W., Kim, S. H., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-04682-w · Cited by 27
Filipčić, I. Š., Ivezić, E., Jakšić, N., Mayer, N., Grah, M., Kuzman, M. R., Bajić, Ž., Švab, V., Herceg, M., & Filipčić, I. (2019) · Early Intervention in Psychiatry · doi:10.1111/eip.12867 · Cited by 26
Epel, E. S. (2020) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2019.19111161 · Cited by 27
Self-citationAge-related changes in physiology in individuals with bipolar disorder
Mutz, J., Young, A. H., & Lewis, C. M. (2021) · Journal of Affective Disorders · doi:10.1016/j.jad.2021.09.027 · Cited by 29
Månsson, K. N. T., Lindqvist, D., Yang, L. L., Svanborg, C., Isung, J., Nilsonne, G., Bergman-Nordgren, L., El Alaoui, S., Hedman-Lagerlöf, E., Kraepelien, M., et al. (2019) · Translational Psychiatry · doi:10.1038/s41398-019-0668-2 · Cited by 25
Self-citationLeukocyte telomere length is reduced in patients with major depressive disorder
Pisanu, C., Tsermpini, E. E., Σκώκου, Μ., Kordou, Z., Gourzis, P., Assimakopoulos, K., Congiu, D., Meloni, A., Balasopoulos, D., Patrinos, G. P., et al. (2019) · Drug Development Research · doi:10.1002/ddr.21612 · Cited by 25
Shorter telomere length in people with schizophrenia: A preliminary study from Australia
Galletly, C. A., Dhillon, V. S., Liu, D., Balzan, R. P., Hahn, L. A., & Fenech, M. F. (2017) · Schizophrenia Research · doi:10.1016/j.schres.2017.03.007 · Cited by 27
Genetic Risk for Psychiatric Disorders and Telomere Length
Palmos, A., Breen, G. D., Goodwin, L., Frissa, S., Hatch, S. L., Hotopf, M. H., Thuret, S., Lewis, C. M., & Powell, T. R. (2018) · Frontiers in Genetics · doi:10.3389/fgene.2018.00468 · Cited by 28
Leukocyte telomere length and hippocampus volume: a meta-analysis
Nilsonne, G., Tamm, S., Månsson, K. N. T., Åkerstedt, T., & Lekander, M. (2015) · F1000Research · doi:10.12688/f1000research.7198.1 · Cited by 23
Association of chronic fatigue syndrome with premature telomere attrition
Rajeevan, M. S., Murray, J., Oakley, L. P., Lin, J.-M. S., & Unger, E. R. (2018) · Journal of Translational Medicine · doi:10.1186/s12967-018-1414-x · Cited by 27
Self-citationTesting three hypotheses about effects of sensitive–insensitive parenting on telomeres.
Beijers, R., Hartman, S., Shalev, I., Hastings, W. J., Mattern, B. C., de Weerth, C., & Belsky, J. (2020) · Developmental Psychology · doi:10.1037/dev0000879 · Cited by 27
Michalek, J. E., Kepa, A., Vincent, J. B., Frissa, S., Goodwin, L., Hotopf, M. H., Hatch, S. L., Breen, G. D., & Powell, T. R. (2017) · Journal of Affective Disorders · doi:10.1016/j.jad.2017.01.017 · Cited by 25
Manoliu, A., Bosch, O. G., Brakowski, J., Brühl, A. B., & Seifritz, E. (2017) · Journal of Affective Disorders · doi:10.1016/j.jad.2017.08.022 · Cited by 25
Telomere shortening in blood leukocytes of patients with posttraumatic stress disorder
Avetyan, D., Zakharyan, R., Petřek, M., & Arakelyan, A. (2019) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2019.01.018 · Cited by 24
Solana, C., Pereira, D., & Tarazona, R. (2018) · Brain Sciences · doi:10.3390/brainsci8100188 · Cited by 23
Enriching CBT by Neuroscience: Novel Avenues to Achieve Personalized Treatments
Månsson, K. N. T., Lueken, U., & Frick, A. (2020) · International Journal of Cognitive Therapy · doi:10.1007/s41811-020-00089-0 · Cited by 25
Kang, J. I., Park, C. I., Lin, J., Kim, S. T., Kim, H. W., & Kim, S. J. (2021) · Journal of Psychiatry and Neuroscience · doi:10.1503/jpn.200238 · Cited by 21
Self-citationHerrera‐Moreno, J. F., Estrada‐Gutiérrez, G., Wu, H., Bloomquist, T. R., Rosa, M. J., Just, A. C., Lamadrid‐Figueroa, H., Téllez‐Rojo, M. M., Wright, R. O., & Baccarelli, A. (2021) · Environmental Research · doi:10.1016/j.envres.2021.112577 · Cited by 21
Jung, J., McCartney, D. L., Wagner, J., Rosoff, D. B., Schwandt, M. L., Sun, H., Wiers, C. E., de Carvalho, L. M., Volkow, N. D., Walker, R. M., et al. (2022) · Molecular Psychiatry · doi:10.1038/s41380-022-01624-5 · Cited by 23
Subjective Overview of Accelerated Aging in Schizophrenia
Seeman, M. V. (2022) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph20010737 · Cited by 21
Telomere length in alcohol dependence: A role for impulsive choice and childhood maltreatment
Kang, J. I., Hwang, S. S., Choi, J. R., Lee, S., Kim, J., Hwang, I. S., Kim, H. W., Kim, C., & Kim, S. J. (2017) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2017.05.024 · Cited by 20
Udomsinprasert, W., Poovorawan, Y., Chongsrisawat, V., Vejchapipat, P., Jittikoon, J., & Honsawek, S. (2019) · Mitochondrion · doi:10.1016/j.mito.2019.04.006 · Cited by 21
Tannous, J. D., Mwangi, B., Hasan, K. M., Narayana, P. A., Steinberg, J. L., Walss‐Bass, C., Moeller, F. G., Schmitz, J. M., & Lane, S. D. (2019) · PLoS ONE · doi:10.1371/journal.pone.0199729 · Cited by 23
Biochemical Correlates of Video Game Use: From Physiology to Pathology. A Narrative Review
Carpita, B., Muti, D., Nardi, B., Benedetti, F., Cappelli, A., Cremone, I. M., Carmassi, C., & Dell’Osso, L. (2021) · Life · doi:10.3390/life11080775 · Cited by 20
Zhang, Y., Hishimoto, A., Otsuka, I., Watanabe, Y., Numata, S., Yamamori, H., Boku, S., Horai, T., Someya, T., Ohmori, T., et al. (2018) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2018.05.014 · Cited by 20
Kim, N., Sung, J. Y., Park, J. Y., Kong, I. D., Hughes, T. L., & Kim, D.-K. (2018) · Social Science & Medicine · doi:10.1016/j.socscimed.2018.12.026 · Cited by 20
Çevik, B., Çalışır, Ö. M., Atbaşoğlu, E. C., Saka, M. C., Alptekın, K., Üçok, A., Sırmatel, B., Gülöksüz, S., Tükün, A., van Os, J., et al. (2019) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2019.01.022 · Cited by 21
Asplund, R. P., Jäderlind, A., Björk, I. H., Ljótsson, B., Carlbring, P., & Andersson, G. (2019) · Internet Interventions · doi:10.1016/j.invent.2019.100282 · Cited by 20
He, S., Li, J., Wang, Z., Wang, L., Liu, L., Sun, X., Shohaib, S. A., & Koenig, H. G. (2020) · Journal of Affective Disorders · doi:10.1016/j.jad.2020.05.082 · Cited by 19
Bazaz, M. R., Balasubramanian, R., Monroy‐Jaramillo, N., & Dandekar, M. P. (2021) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.1c00457 · Cited by 20
Serhiyenko, V. A., Holzmann, K., Holota, S. M., Derkach, Z., Nersesyan, A. K., Melnyk, S., Chernysh, O., Yatskevych, O., Mišík, M., Bubalo, V., et al. (2022) · Proceedings of the Shevchenko Scientific Society Medical Sciences · doi:10.25040/ntsh2022.02.14 · Cited by 19
Depression, aging, and immunity: implications for COVID-19 vaccine immunogenicity
Ford, B. N., & Savitz, J. B. (2022) · Immunity & Ageing · doi:10.1186/s12979-022-00288-7 · Cited by 18
Reckziegel, R. D. F. X., Czepielewski, L. S., Hasse-Sousa, M., Martins, D. S., de Britto, M. J. S., Lapa, C. D. O., Schwartzhaupt, A. W., & Gama, C. S. (2021) · Brazilian Journal of Psychiatry · doi:10.1590/1516-4446-2020-1670 · Cited by 24
Liu, J. J., Wei, Y. B., Forsell, Y., & Lavebratt, C. (2017) · Journal of Affective Disorders · doi:10.1016/j.jad.2017.07.007 · Cited by 18
de Punder, K., Heim, C. C., Przesdzing, I., Wadhwa, P. D., & Entringer, S. (2018) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.2016.0441 · Cited by 17
Telomere length as a predictor of emotional processing in the brain
Powell, T. R., de Jong, S., Breen, G. D., Lewis, C. M., & Dima, D. (2018) · Human Brain Mapping · doi:10.1002/hbm.24487 · Cited by 17
Steward, A. M., Morgan, J. D., Espinosa, J. P., Turk, D. C., & Patel, K. V. (2017) · The Journal of Pain · doi:10.1016/j.jpain.2017.08.006 · Cited by 16
Unraveling the association between depression and telomere length using genomics
Verhoeven, J. E., Penninx, B. W. J. H., & Milaneschi, Y. (2018) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2018.11.029 · Cited by 17
Self-citationThe Impact of Health Promotion Interventions on Telomere Length: A Systematic Review
Qiao, S., Jiang, Y., & Li, X. (2020) · American Journal of Health Promotion · doi:10.1177/0890117120906958 · Cited by 16
Association between Telomere Length and Pediatric Obesity: A Systematic Review
Raftopoulou, C., Paltoglou, G., & Charmandari, E. (2022) · Nutrients · doi:10.3390/nu14061244 · Cited by 16
van Gastel, J., Hendrickx, J. O., Leysen, H., Martin, B., Veenker, L., Beuning, S., Coppens, V., Morrens, M., & Maudsley, S. R. (2019) · Methods in molecular biology · doi:10.1007/978-1-4939-9554-7_39 · Cited by 16
Manchia, M., Paribello, P., Arzedi, C., Bocchetta, A., Caria, P., Cocco, C., Congiu, D., Cossu, E., Dettori, T., Frau, D. V., et al. (2020) · BMJ Open · doi:10.1136/bmjopen-2019-032513 · Cited by 15
Provenzi, L., di Minico, G. S., Giorda, R., & Montirosso, R. (2017) · Frontiers in Endocrinology · doi:10.3389/fendo.2017.00295 · Cited by 15
Shortened leukocyte telomere length in young adults who use methamphetamine
Lin, K., Chen, P., Liu, H., Chen, Y.-L., Chou, W.-H., & Huang, M. (2021) · Translational Psychiatry · doi:10.1038/s41398-021-01640-z · Cited by 13
Yang, C., Hou, X., Ma, X., & Wu, D. (2023) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2022.1067260 · Cited by 14
Epigenetic Age Acceleration and Disparities in Posttraumatic Stress in Women in Southeast Louisiana
Smith, A. K., Katrinli, Ş., Cobb, D. O., Goff, E. G., Simmond, M., Christensen, G. M., Prusisz, T., Garth, S. N., Brashear, M. M., Hüls, A., et al. (2024) · JAMA Network Open · doi:10.1001/jamanetworkopen.2024.21884 · Cited by 15
Iloabuchi, C., Innes, K. E., & Sambamoorthi, U. (2020) · Sleep Health · doi:10.1016/j.sleh.2019.12.003 · Cited by 14
McIntosh, R. C., Lobo, J. D., Paparozzi, J., Goodman, Z., Kornfeld, S., & Nomi, J. S. (2022) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2022.577831 · Cited by 13
Feng, Y., Shen, J., He, J. H., & Lu, M. (2023) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2023.1105987 · Cited by 13
Amidfar, M., Karami, Z., Kheirabadi, G. R., Afshar, H., & Esmaeili, A. (2019) · Journal of Research in Medical Sciences · doi:10.4103/jrms.jrms_811_17 · Cited by 13
Hamad, R., Nguyen, T. T. X., Glymour, M. M., Vable, A. M., Manly, J. J., & Rehkopf, D. H. (2019) · Preventive Medicine · doi:10.1016/j.ypmed.2019.06.008 · Cited by 14
Ämmälä, A., Suvisaari, J., Kananen, L., Lönnqvist, J. K., Ripatti, S., Pirkola, S. P., Paunio, T., & Hovatta, I. (2021) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2021.105276 · Cited by 12
del Campo, C. M. Z.-M., Rosas, M., & Guarner‐Lans, V. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19051456 · Cited by 12
Ashrafi, A., Cosentino, S., Kang, M. S., Lee, J. H., Schupf, N., Andersen, S. L., Christensen, K., Province, M. A., Thyagarajan, B., Zmuda, J. M., et al. (2020) · Journal of the International Neuropsychological Society · doi:10.1017/s1355617720000363 · Cited by 12
Polho, G. B., Cardillo, G. M., Kerr, D. S., Chile, T., Gattaz, W. F., Forlenza, O. V., Brentani, H., & De-Paula, V. J. (2021) · Neural Regeneration Research · doi:10.4103/1673-5374.324852 · Cited by 12
Bauernfreund, Y., Launders, N., Favarato, G., Hayes, J., Osborn, D., & Sampson, E. L. (2022) · Acta Psychiatrica Scandinavica · doi:10.1111/acps.13480 · Cited by 12
Pino, O., Cadena, R. T., & Poli, D. (2022) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph191912615 · Cited by 15
Rampersaud, R., Wu, G. W. Y., Reus, V. I., Lin, J., Blackburn, E. H., Epel, E. S., Hough, C. M., Mellon, S. H., & Wolkowitz, O. M. (2023) · Scientific Reports · doi:10.1038/s41598-023-35912-z · Cited by 12
Self-citationFrailty and psychiatric disorders: A bidirectional Mendelian randomization study
Chen, J.-H., Lei, H., Wan, Y.-F., Zhu, X.-C., Zeng, L.-Y., Tang, H.-X., Zhao, Y., Pan, Y., Deng, Y.-Q., & Liu, K. (2024) · Journal of Affective Disorders · doi:10.1016/j.jad.2024.04.024 · Cited by 13
The Role of Glia Telomere Dysfunction in the Pathogenesis of Central Nervous System Diseases
Papageorgakopoulou, M. A., Bania, A., Lagogianni, I.-A., Birmpas, K., & Assimakopoulou, M. (2024) · Molecular Neurobiology · doi:10.1007/s12035-024-03947-6 · Cited by 13
Targets and regulation of microRNA-652-3p in homoeostasis and disease
Stevens, M. T., & Saunders, B. M. (2021) · Journal of Molecular Medicine · doi:10.1007/s00109-021-02060-8 · Cited by 11
Li, L., Qin, K., Chen, D., Lu, C., Chen, W., & Guo, V. Y. (2021) · Acta Paediatrica · doi:10.1111/apa.15971 · Cited by 12
Shivakumar, V., Kalmady, S. V., Rajasekaran, A., Chhabra, H., Amaresha, A. C., Narayanaswamy, J. C., Ravi, V., Gangadhar, B. N., & Venkatasubramanian, G. (2018) · Psychiatry Research Neuroimaging · doi:10.1016/j.pscychresns.2018.10.002 · Cited by 13
van Gastel, J., Cai, H., Cong, W., Chadwick, W., Daimon, C. M., Leysen, H., Hendrickx, J. O., Schepper, R. D., Vangenechten, L., Turnhout, J. V., et al. (2019) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2019.111150 · Cited by 11
Schröder, J. D., de Araújo, J. B., de Oliveira, T., de Moura, A. B., Fries, G. R., Quevedo, J., Réus, G. Z., & Ignácio, Z. M. (2021) · Reviews in the Neurosciences · doi:10.1515/revneuro-2021-0070 · Cited by 12
Khan, R., Gebreab, S. Y., Crespo, P. R., Xu, R., Gaye, A., & Davis, S. (2017) · Quality of Life Research · doi:10.1007/s11136-017-1610-9 · Cited by 11
Neuronal and Non-Neuronal GABA in COVID-19: Relevance for Psychiatry
Sfera, A., Thomas, K. G., Sasannia, S., Anton, J. J., Andronescu, C. V., Garcia, M., Sfera, D. O., Cummings, M. A., & Kozlakidis, Z. (2022) · Reports — Medical Cases Images and Videos · doi:10.3390/reports5020022 · Cited by 11
Ma, R., Romano, E., Ashworth, M., Yadegarfar, M. E., Dregan, A., Ronaldson, A., de Oliveira, C., Jacobs, R., Stewart, R. J., & Stubbs, B. (2022) · Psychological Medicine · doi:10.1017/s003329172200109x · Cited by 11
Fair, B., Mellon, S. H., Epel, E. S., Lin, J., Révész, D., Verhoeven, J. E., Penninx, B. W. J. H., Reus, V. I., Rosser, R., Hough, C. M., et al. (2017) · Journal of Psychosomatic Research · doi:10.1016/j.jpsychores.2017.06.009 · Cited by 10
Self-citationJenkins, F. J., Kerr, C. M., Fouquerel, E., Bovbjerg, D. H., & Opresko, P. L. (2017) · Journal of Visualized Experiments · doi:10.3791/56001 · Cited by 10
Zhang, C., Xu, Y., Hua, Y., Li, P., Storey, K. B., & Zhang, W. (2023) · Freshwater Biology · doi:10.1111/fwb.14153 · Cited by 9
DHEA Moderates the Impact of Childhood Trauma on the HPA Axis in Adolescence
Taylor-Cavelier, S. J., Micol, V. J., Roberts, A. G., Geiss, E. G., & Lopez‐Duran, N. L. (2021) · Neuropsychobiology · doi:10.1159/000511629 · Cited by 12
Accelerated aging signatures in subjects with schizophrenia and their unaffected siblings
Rebouças, D. B., Sartori, J., Librenza‐Garcia, D., Rabelo‐da‐Ponte, F. D., Massuda, R., Czepielewski, L. S., Passos, I. C., & Gama, C. S. (2021) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2021.04.029 · Cited by 9
The researcher's guide to selecting biomarkers in mental health studies
Verhoeven, J. E., Wolkowitz, O. M., Satz, I. B., Conklin, Q. A., Lamers, F., Lavebratt, C., Lin, J., Lindqvist, D., Mayer, S. E., Melas, P. A., et al. (2024) · BioEssays · doi:10.1002/bies.202300246 · Cited by 10
Self-citationKalungi, A., Womersley, J. S., Kinyanda, E., Joloba, M. L., Ssembajjwe, W. J., Nsubuga, R. N., Levin, J. B., Kaleebu, P., Kidd, M., Seedat, S., et al. (2019) · Frontiers in Genetics · doi:10.3389/fgene.2019.00705 · Cited by 8
Inverse changes in telomere length between the blood and brain in depressive-like mice
Liu, Z., Han, R., Zhu, W., Xiu, J., Shen, Y., & Xu, Q. (2020) · Journal of Affective Disorders · doi:10.1016/j.jad.2020.01.089 · Cited by 11
Environmental exposures and health behavior in association with mental health: a study design
Hautekiet, P., Nawrot, T. S., Demarest, S. S., der Heyden, J. V., Overmeire, I. V., Clercq, E. M. D., & Saenen, N. D. (2020) · Archives of Public Health · doi:10.1186/s13690-020-00477-0 · Cited by 8
Are Psychosocial Resources Associated With Perceived Facial Aging in Men?
Noser, E., Walther, A., & Ehlert, U. (2017) · Gerontology and Geriatric Medicine · doi:10.1177/2333721417714875 · Cited by 8
González, J. L. S., Sánchez-Gil, A., Vicente-Muñoz, E., Navarro‐López, V., Martín‐Vallejo, J., & Pérez, J. (2025) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2025.04.001 · Cited by 9
Carvalho, C. M., Coimbra, B. M., Xavier, G., Bugiga, A., Fonseca, T., Olff, M., Polimanti, R. A., Mello, A. F., Ota, V., Mello, M. F., et al. (2022) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2022.835783 · Cited by 7
Long or short? Telomere length and pancreatic cancer and its precursor lesions, a narrative review
Campa, D., Felici, A., Corradi, C., Peduzzi, G., Gentiluomo, M., Farinella, R., & Rizzato, C. (2023) · Mutagenesis · doi:10.1093/mutage/gead034 · Cited by 8
Association between leukocyte telomere length and hostility in US army service members
Zhang, L. J., Hu, X., Russell, D. W., Benedek, D. M., Fullerton, C. S., Naifeh, J. A., Li, X., Chen, Z., Wu, H., Ng, T. H. H., et al. (2019) · Neuroscience Letters · doi:10.1016/j.neulet.2019.04.020 · Cited by 7
Womersley, J. S., Xulu, K. R., Sommer, J. E., Hinsberger, M., Kidd, M., Elbert, T. R., Weierstall, R., Kaminer, D., Malan‐Müller, S., Seedat, S., et al. (2021) · Neuroscience Letters · doi:10.1016/j.neulet.2021.136388 · Cited by 8
Associations of depression and anxiety and adolescent telomere length
Ford, J. L., Pickler, R. H., Browning, C. R., Tarrence, J., Anderson, A. M., & Kertes, D. A. (2023) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2023.106310 · Cited by 7
Carroll, J., Olmstead, R., Haque, R., & Irwin, M. R. (2022) · Cancer · doi:10.1002/cncr.34329 · Cited by 6
Metadata
- Authors
- Lindqvist, D., Epel, E. S., Mellon, S. H., Penninx, B. W., Révész, D., Verhoeven, J. E., Reus, V. I., Lin, J., Mahan, L., Hough, C. M., Rosser, R., Bersani, F. S., Blackburn, E. H., & Wolkowitz, O. M.
- Affiliations
- University of California, San Francisco (US)
- Amsterdam Public Health (NL)
- Corresponding author
- Wolkowitz, Owen M.
- ORCID
- Venue
- Neuroscience & Biobehavioral Reviews
- Publisher
- Elsevier BV
- Published
- 2015-08
- Volume
- 55
- Pages
- 333-364
- ISSN
- 0149-7634 (ISSN-L)
- PMC
- PMC4501875
- OpenAlex
- W1733523167
- Cited by
- 285
- References
- 230
- Citations by year
- 2026: 6 · 2025: 11 · 2024: 12 · 2023: 23 · 2022: 31 · 2021: 31 · 2020: 24 · 2019: 34 · 2018: 36 · 2017: 33 · 2016: 31 · 2015: 12
- FWCI
- 4.56
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Neuroscience & Biobehavioral Reviews (publishedVersion)
- PubMed (publishedVersion)
- Pure Amsterdam UMC (publishedVersion)
- Amsterdam UMC (VU Amsterdam) - Institutional Repository (publishedVersion)
- VU Research Portal (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- eScholarship (California Digital Library) (submittedVersion)
- IRIS Research product catalog (Sapienza University of Rome) (submittedVersion)
- Lund University Publications (Lund University) (submittedVersion)
- Data Archiving and Networked Services (DANS) (submittedVersion)
- Funders
- National Institute on Aging (R01AG030424, 01AG030424-01A1)
- National Institute of Mental Health (R01MH083784)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Aging › Genetics, Aging, and Longevity in Model Organisms
- Life Sciences › Neuroscience › Behavioral Neuroscience › Stress Responses and Cortisol
- Keywords
- leukocyte telomere length, cellular aging, mental illness, telomerase activity, depression, inflammation, oxidative stress, cellular senescence, mortality, systemic disease
- MeSH terms
- Adolescent, Adult, Aged, Mental Disorders, Child, Female, Humans, Leukocytes, Male, Middle Aged, Telomere, Cellular Senescence, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review